[After care in colorectal cancer].
The poor results of nonsurgical cancer therapy in locally recurring colorectal carcinoma and its metastases urge for an early diagnosis of these complications. Serial CEA-levels are the most promising tool to detect even preclinical tumour-growth. Because the incidence of tumor recurrence or metastases is highest in the first and second year after surgery the follow-up of the patients should be as close as possible during this time.
Brunner
H
H
I. Interen Abteilung mit Gastroenterologie, Krankenhauses der Elisabethinen, Linz.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002272:Carcinoembryonic Antigen / Q000032:analysis; D015179:Colorectal Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000601:surgery; D003131:Combined Modality Therapy; D005500:Follow-Up Studies; D006801:Humans; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis* / Q000188:drug therapy / Q000601:surgery
D002272:Carcinoembryonic Antigen
Nachsorge beim kolorektalen Karzinom.